eli lilly zepbound news - Search News

Eli Lilly, Food and Drug Administration

Barron's on MSN · 2d

Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

The Washington Post · 1d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Fast Company on MSN · 2d

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

2d

This IPO Biotech Stock Could Be the Next Eli Lilly

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

2don MSN

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

3don MSN

Eli Lilly to build $4.5 billion Indiana facility for advanced drug manufacturing

Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development ...

2d

Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results